The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Onto Innovation Inc
NYSE:ONTO
|
US |
|
NAPCO Security Technologies Inc
F:NS1
|
US |
|
S
|
St Barbara Ltd
OTC:STBMF
|
AU |
|
ON Semiconductor Corp
NASDAQ:ON
|
US |
|
China Shenhua Energy Co Ltd
SSE:601088
|
CN |
|
H
|
Heineken Holding NV
XMUN:4H5
|
NL |
|
E
|
Equifax Inc
F:EFX
|
US |
|
N
|
NCC Group PLC
SWB:NZB
|
UK |
|
Y
|
Yoma Strategic Holdings Ltd
F:O3B
|
SG |
|
A
|
AmeriGuard Security Services Inc
OTC:AGSS
|
US |
|
Tiziana Life Sciences Ltd
F:0RP
|
UK |
|
N
|
Nokia Oyj
F:NOAA
|
FI |
|
S
|
SoftBank Group Corp
SWB:SFTU
|
JP |
|
H
|
HEM Pharma Inc
KOSDAQ:376270
|
KR |
|
Innovex International Inc
F:DQU0
|
US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
US |
|
P
|
Pacifica Holdings Inc
XPHS:PA
|
PH |
|
M
|
Merck & Co Inc
LSE:0QAH
|
US |
|
Cineverse Corp
NASDAQ:CNVS
|
US |
|
Foghorn Therapeutics Inc
NASDAQ:FHTX
|
US |
|
A
|
Adamjee Life Assurance Co Ltd
KAR:ALIFE
|
PK |
|
IPH Ltd
F:1IP
|
AU |
|
R
|
Royal Bank of Canada
XMUN:RYC
|
CA |
Onto Innovation Inc (ONTO)’s 12-month stock price forecast through November 2027 has a consensus target of $397.8, implying 151% upside. The forecast is based on price targets from 15 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
ONTO is 397.8 USD with a low forecast of 333.3 USD and a high forecast of 472.5 USD.
Over the last 13 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 5 years is 23%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 5 years is 26%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 32%. The projected CAGR for the next 5 years is 38%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 32%. The projected CAGR for the next 3 years is 68%.
Over the last 13 years, the compound annual growth rate for Net Income has been 30%. The projected CAGR for the next 5 years is 46%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more